Navigation Links
Senate Introduces Legislation to Increase Access to Physical Therapist Services
Date:5/6/2009

ALEXANDRIA, Va., May 6 /PRNewswire-USNewswire/ -- The US Senate recently introduced legislation that would increase access to physical therapy services for Medicare beneficiaries by removing the need for a physician's referral or certification of the plan of care in those states in which direct access is authorized, says the American Physical Therapy Association (APTA).

Under the Medicare Patient Access to Physical Therapists Act (S 950), introduced by Senators Blanche Lincoln (D-AR), Lindsey Graham (R-SC), and Arlen Specter (D-PA), Medicare Part B beneficiaries who need outpatient physical therapy would have direct access to physical therapist services as permitted by state law.

"Delaying treatment puts seniors and people with disabilities at risk by impeding their ability to achieve optimal functional outcomes," said APTA President R. Scott Ward, PT, Ph.D. "Removing this unnecessary and burdensome requirement will allow Medicare beneficiaries to receive high quality cost-effective physical therapy services in a timely manner."

Forty-eight states and the District of Columbia have eliminated the physician referral/certification of plan requirement for patients to access physical therapists for an evaluation, while 44 states and DC allow access to some form of physical therapy treatment without referral. This legislation would defer to the state law on access regarding physical therapy.

"As we work to move health care toward a system that improves quality and value, physical therapists are critical to increasing access to care, especially in rural America," said Lincoln. "Our health reform efforts should enable providers to work collaboratively across care settings to deliver evidence-based health care services to the millions of Medicare beneficiaries who need them."

The House introduced its version of the Senate bill on March 31.

Physical therapists are highly-educated, licensed health care professionals who can help patients reduce pain and improve or restore mobility - in many cases without expensive surgery or the side effects of prescription medications. APTA represents more than 72,000 physical therapists, physical therapist assistants, and students of physical therapy nationwide. Its purpose is to improve the health and quality of life of individuals through the advancement of physical therapist practice, education, and research. In most states, patients can make an appointment directly with a physical therapist, without a physician referral. Learn more about conditions physical therapists can treat and find a physical therapist in your area at www.moveforwardpt.com.


'/>"/>
SOURCE American Physical Therapy Association
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. American Association for Homecare Applauds Senate STOP Act, Which Aims to Prevent Medicare Fraud and Abuse
2. Steinberg Announces Senate Select Committee on Autism and Related Disorders
3. WellPoint Statement on Senate Finance Committee Health Reform Options Paper
4. Pelosi Statement on Senate Confirmation of Kathleen Sebelius as Health and Human Services Secretary
5. Consumer Watchdog: U.S. Senate Records Reveal Google Inc. Lobbying Campaign on Personal Medical Records Law Despite Internet Giants Denials
6. Lung Cancer Research Bill Introduced in the U.S. House of Representatives: Companion to Senate Mortality Reduction Bill
7. Coalition to Protect Senior Care Applauds Inclusion of Long Term Care in Senate Finance Committee Roundtable Discussion on Health Care Delivery System Reform
8. American Association for Homecare Applauds Senate Subcommittee Efforts to Prevent Waste and Fraud in Medicare; Association Presents 13-Point Legislative Plan to Stop Waste and Fraud
9. XLHealth Statement on Senate Finance Committee Roundtable on Healthcare Reform
10. PHR: After Senate Report, Psychologists Who Tortured Must Be Held to Account
11. Texas Health Care Association: Senate Budget Woefully Inadequate in Funding Seniors Medicaid-Financed Nursing Home Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are held ... with process innovation in drug formulation and manufacturing. CoreRx offers its clients ... equipment in support of their development and manufacturing goals. , The company ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest ... chronic problems, I focus on preventative care with all my patients to alleviate possible future ... always feel free to contact my office and my trained staff will assist you in ...
(Date:4/25/2017)... ... April 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency ... Series, Outliers in Writing, set to publish in summer 2017. , Dr. Bobrow, ... University of Arizona College of Medicine. He also serves as Medical Director for the ...
(Date:4/25/2017)... ... ... Vetoquinol USA® , a world-class developer of veterinarian-approved ... EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin UCII ... The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and joints. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Company,s consumer product development program, based on its ... for Investigative Dermatology (SID) 76 th Annual ... promote the sciences relevant to skin health and ...
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
Breaking Medicine Technology: